Advances in Alzheimer’s and Parkinson’s Therapies
Visit us at the Advances in Alzheimer’s and Parkinson’s Therapies Focus Meeting!
March 15-18, 2018
Stop by our booth for live demonstrations of APDM’s Mobility Lab at the Advances in Alzheimer’s and Parkinson’s Therapies Focus Meeting in Torino, Italy. Used by thousands of researchers and clinicians worldwide, Mobility Lab provides sensitive, reliable, and valid outcome measures for assessing functional mobility anywhere. These outcome measures provide actionable data for early detection of mild cognitive impairment and neurological disorders like Parkinson’s disease, Ataxia, Cerebral Palsy, and others.
The Advances in Alzheimer’s and Parkinson’s Therapies (AAT-AD/PD) Focus Meeting is a new joint meeting between the International Geneva and Springfield Symposium. This Alzheimer’s and Parkinson’s disease conference will showcase the latest breakthroughs in treatment, translational research and development, early diagnosis, drug development and clinical trials in Alzheimer’s, Parkinson’s and other related neurological disorders.
Mobility Lab makes it easy to collect, analyze, and store data. Within minutes you can set up, attach APDM’s Opal wearable sensors to your subject, instruct them to perform a standardized test, and get instant results. This automated report provides spatiotemporal parameters that can track a patient’s progress longitudinally or determine intervention response.
APDM’s Matthew Johnson will be providing demonstrations of the gait and balance solution, Mobility Lab, currently being used in clinical trials for Parkinson’s disease, Ataxia, and Huntington’s disease.